Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+ T cells

Research output: Contribution to journalJournal articleResearchpeer-review

To examine if polymorphism 80G --> A in the Reduced Folate Carrier (RFC) affects uptake of MTX in B- and CD4+ T-cells.
Original languageEnglish
JournalRheumatology
Volume47
Issue number4
Pages (from-to)451-3
Number of pages3
ISSN1462-0324
DOIs
Publication statusPublished - 1 Apr 2008

ID: 34078256